|
GB201303406D0
|
|
Crimean-Congo Haemorrhagic Fever Virus Antigenic Composition
|
|
GB201301200D0
|
|
Detection device and assay
|
|
GB201206190D0
|
|
Decontaminant product and method
|
|
GB201206070D0
|
|
Clostridium difficile antigens
|
|
GB201201055D0
|
|
Detection device and assay
|
|
GB201121210D0
|
|
Respiratory infection assay
|
|
GB201115911D0
|
|
Thermostable assay reagents
|
|
GB201115214D0
|
|
Influenza virus antibody compositions
|
|
GB201111723D0
|
|
Salmonella detection assay
|
|
GB201110980D0
|
|
Neisserial compositions and expression constructs
|
|
GB201022077D0
|
|
Inactivated poliovaccine
|
|
WO2011077143A1
|
|
Transformation of commensal neisseria
|
|
GB201016742D0
|
|
Clostridium difficile antigens
|
|
GB201011587D0
|
|
Detection of drug-resistant influenza virus
|
|
GB201008512D0
|
|
Mycobacterial antigen composition
|
|
CN102365097A
|
|
Antibodies to clostridium difficile toxins
|
|
GB0921288D0
|
|
Therapies for preventing or suppressing clostridium difficile infection
|
|
GB0921048D0
|
|
Assay method and apparatus
|
|
GB0916557D0
|
|
Commensal neisserial stress protein complexes
|
|
GB0916153D0
|
|
Antibodies to clostridium difficile toxins
|
